The Valley Desk

NCT01353248 · Interventional trial

GS 5885 Administered Concomitantly With GS-9451, Tegobuvir and Ribavirin (RBV) in Chronic Genotype 1 Hepatitis C Virus (HCV) Infection

Overall registry status Completed

Phase 2

Conditions Hepatitis C, Chronic

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov